Ninety day mortality in haematological malignancies in adolescent and young adults: Efforts to buck the trend

摘要

Adolescents and young adults (AYAs) constitute 6.26 to 7.63% of all cancers in India, accounting for 80000 new cases every year. Survival rates among AYAs are poor, in contrast to the pediatric age group and even older adults according to SEER and the GLOBOCON 2018 data. Leukemia, lymphomas are curable entities in other age-epochs, but death rates of these malig- nancies in TYA continue to be unacceptably high globally. The present paper highlights the single institution monitoring of ninety day mortality among TYAs with leukemia & lymphoma. Ninety day mortality was chosen as benchmark for study as intensive induction therapy is usually completed within this period indicating acceptable patient tolerance.